Category Specific RSS

pxs

Shareholders back Pharmaxis liver cancer treatment trials via oversubscribed capital raise

When the University of Rochester came knocking on the door of biopharmaceutical company Pharmaxis (ASX: PXS), it was a boost…

4 years ago

Global biotech funds commit $7.2m to breakthrough liver and bone cancer trials

Breakthrough clinical trials into new treatments for bone marrow and liver cancer will soon commence after experienced institutional biotech investors…

4 years ago

Dosing complete, Pharmaxis progresses with skin scarring trials led by Professor Fiona Wood

Our scars tell a story, whether it be grazed knees from the school yard or those mystery scrapes that make…

4 years ago